Visby Medical

The first commercial application of the Visby Medical single-use, rapid PCR platform received FDA EUA in 2020 for COVID-19 testing. Currently under review with the FDA is a multiplex assay for Chlamydia, Gonorrhea, and Trichomonas from a single sample, at the point of care.

Jant Pharmacal Corp

Jant Pharmacal, established in 1986, offers a wide range of CLIA-waived tests for Urgent Care practices. FDA EUA CLIA-waived Covid-19 antigen tests are available in both Flu A&B/Covid-19 and single Covid-19 formats. Other tests include PT/INR, cardiac enzymes, pregnancy, mononucleosis, H. pylori, Hepatitis C, HIV, urinalysis, iFOBT, DOA and UTI.

Sekisui Diagnostics

For over 40 years SEKISUI Diagnostics has been committed to providing innovative medical diagnostics to physicians and laboratories. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our sales channels and our distribution/business partners. Our product lines include point-of-care molecular, rapid tests and immunoassay system as well asRead More